Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics. CA Cancer J Clin. 2021;71(1):7–33.

PubMed  Google Scholar 

Park W, Chawla A, O’Reilly EM. Pancreatic cancer: a review. JAMA. 2021;326(9):851–62.

CAS  PubMed  Article  Google Scholar 

Grech G, Zhan X, Yoo BC, Bubnov R, Hagan S, Danesi R, et al. EPMA position paper in cancer: current overview and future perspectives. EPMA J. 2015;6(1):9.

PubMed  PubMed Central  Article  Google Scholar 

Nagaraju GP, Malla RR, Basha R, Motofei IG. Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1. Semin Cancer Biol. 2021; S1044–579X(21)00270–4.

Uhlitz F, Zamarin D. Rejuvenating dysfunctional T cells in ovarian cancer: CD28 is the license to kill. Cancer Cell. 2021;S1535–6108(21):00562–6.

Google Scholar 

Zhang B, Vogelzang A, Miyajima M, Sugiura Y, Wu Y, Chamoto K, et al. B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity. Nature. 2021;599(7885):471–6.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Au L, Hatipoglu E, Robert de Massy M, Litchfield K, Beattie G, Rowan A, et al. TRACERx Renal Consortium. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma. Cancer Cell. 2021;39(11):1497–518.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Nguyen NT, Huang K, Zeng H, Jing J, Wang R, Fang S, et al. Nano-optogenetic engineering of CAR T cells for precision immunotherapy with enhanced safety. Nat Nanotechnol. 2021;16(12):1424–34.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Scheiner B, Pomej K, Kirstein MM, Hucke F, Finkelmeier F, Waidmann O, et al. Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score. J Hepatol. 2021;76(2):353–63.

PubMed  Article  CAS  Google Scholar 

Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359(6382):1350–5.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Mazur PK, Siveke JT. Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology. Gut. 2012;61(10):1488–500.

PubMed  Article  Google Scholar 

Stromnes IM, Hulbert A, Pierce RH, Greenberg PD, Hingorani SR. T-cell localization, activation, and clonal expansion in human pancreatic ductal adenocarcinoma. Cancer Immunol Res. 2017;5(11):978–91.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Jiang ZB, Huang JM, Xie YJ, Zhang YZ, Chang C, Lai HL, et al. Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis. J Exp Clin Cancer Res. 2020;39(1):249.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Schmit K, Michiels C. TMEM proteins in cancer: a review. Front Pharmacol. 2018;9:1345.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Koteluk O, Bielicka A, Lemańska Ż, Jóźwiak K, Klawiter W, Mackiewicz A, et al. The landscape of transmembrane protein family members in head and neck cancers: their biological role and diagnostic utility. Cancers (Basel). 2021;13(19):4737.

CAS  Article  Google Scholar 

Carroll J, He J, Ding S, Fearnley IM, Walker JE. TMEM70 and TMEM242 help to assemble the rotor ring of human ATP synthase and interact with assembly factors for complex I. Proc Natl Acad Sci U S A. 2021;118(13):e2100558118.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Luo S, Wang X, Bai M, Jiang W, Zhang Z, Chen Y, et al. The conserved autoimmune-disease risk gene TMEM39A regulates lysosome dynamics. Proc Natl Acad Sci U S A. 2021;118(6):e2011379118.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Duan J, Qian Y, Fu X, Chen M, Liu K, Liu H, et al. TMEM106C contributes to the malignant characteristics and poor prognosis of hepatocellular carcinoma. Aging (Albany NY). 2021;13(4):5585–606.

CAS  Article  Google Scholar 

Rao J, Wu X, Zhou X, Deng R, Ma Y. TMEM205 is an independent prognostic factor and is associated with immune cell infiltrates in hepatocellular carcinoma. Front Genet. 2020;11:575776.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Listing H, Mardin WA, Wohlfromm S, Mees ST, Haier J. MiR-23a/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancer. Br J Cancer. 2015;112(1):131–9.

CAS  PubMed  Article  Google Scholar 

Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zhang S, Zang D, Cheng Y, Li Z, Yang B, Guo T. Identification of key gene and pathways for the prediction of peritoneal metastasis of gastric cancer by co-expression analysis. J Cancer. 2020;11(10):3041–51.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Hazra A, Gogtay N. Biostatistics series module 3: comparing groups: numerical variables. Indian J Dermatol. 2016;61(3):251–60.

PubMed  PubMed Central  Article  Google Scholar 

Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–9.

CAS  PubMed  Article  Google Scholar 

Xu L, Zhang Y, Liu J, Qu J, Hu X, Zhang F, et al. TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells. Eur J Cancer. 2012;48(17):3288–99.

CAS  PubMed  Article  Google Scholar 

Zang D, Zhang C, Li C, Fan Y, Li Z, Hou K, et al. LPPR4 promotes peritoneal metastasis via Sp1/integrin α/FAK signaling in gastric cancer. Am J Cancer Res. 2020;10(3):1026–44.

CAS  PubMed  PubMed Central  Google Scholar 

Marcq E, Audenaerde JRV, Waele J, Jacobs J, Loenhout JV, Cavents G, et al. Building a bridge between chemotherapy and immunotherapy in malignant pleural mesothelioma: investigating the effect of chemotherapy on immune checkpoint expression. Int J Mol Sci. 2019;20(17):4182.

PubMed Central  Article  CAS  Google Scholar 

Marcq E, Van Audenaerde JRM, De Waele J, Merlin C, Pauwels P, van Meerbeeck JP, et al. The search for an interesting partner to combine with PD-L1 blockade in mesothelioma: focus on Tim-3 and LAG-3. Cancers. 2021;13(2):282.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tanaka A, Sakaguchi S. Regulatory T cells in cancer immunotherapy. CELL RES. 2017;27(1):109–18.

CAS  PubMed  Article  Google Scholar 

Jairath NK, Farha MW, Jairath R, Harms PW, Tsoi LC, Tejasvi T. Prognostic value of intratumoral lymphocyte-to-monocyte ratio and M0 macrophage enrichment in tumor immune microenvironment of melanoma. Melanoma Manag. 2020; 7(4):Mmt51.

Hugo W, Zaretsky JM, Sun L, Song C, Moreno BH, Hu-Lieskovan S, et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell. 2016;165(1):35–44.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ayers M, Lunceford J, Nebozhyn M, Murphy E, Loboda A, Kaufman DR, et al. IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade. J Clin Invest. 2017;127(8):2930–40.

PubMed  PubMed Central  Article  Google Scholar 

Snyder A, Makarov V, Merghoub T, Yuan J, Zaretsky JM, Desrichard A, et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med. 2014;371(23):2189–99.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ, et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science (New York, NY). 2015;348(6230):124–8.

CAS  PubMed Central  Article  Google Scholar 

Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747–56.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, et al. Pancreatic cancer. Nat Rev Dis Primers. 2016;2:16022.

PubMed  Article  Google Scholar 

Dreyer SB, Chang DK, Bailey P, Biankin AV. Pancreatic cancer genomes: implications for clinical management and therapeutic development. Clin Cancer Res. 2017;23(7):1638–46.

PubMed  Article  Google Scholar 

Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M, et al. Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016. EPMA J. 2016;7(1):23.

PubMed  PubMed Central  Article  Google Scholar 

Foley K, Kim V, Jaffee E, Zheng L. Current progress in immunotherapy for pancreatic cancer. Cancer Lett. 2016;381(1):244–51.

CAS  PubMed  Article